These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11782598)

  • 1. Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene.
    Andréoletti L; Weiss L; Si-Mohamed A; Piketty C; Prazuck T; Calamy G; Malkin JE; Matta M; Mbopi-Kéou FX; Clavel F; Kazatchkine MD; Bélec L
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):102-4. PubMed ID: 11782598
    [No Abstract]   [Full Text] [Related]  

  • 2. Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
    Quiñones-Mateu ME; Tadele M; Parera M; Mas A; Weber J; Rangel HR; Chakraborty B; Clotet B; Domingo E; Menéndez-Arias L; Martínez MA
    J Virol; 2002 Oct; 76(20):10546-52. PubMed ID: 12239335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
    Kaye S; Comber E; Tenant-Flowers M; Loveday C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1221-5. PubMed ID: 8573378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive Drug-resistant Mutation Profiles and Interpretations of HIV-1 Proviral DNA Revealed by Deep Sequencing in Reverse Transcriptase.
    Yin QQ; Li ZP; Zhao H; Pan D; Wang Y; Xu WS; Xing H; Feng Y; Jiang SB; Shao YM; Ma LY
    Biomed Environ Sci; 2016 Apr; 29(4):239-47. PubMed ID: 27241734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proviral DNA as a Target for HIV-1 Resistance Analysis.
    Lübke N; Di Cristanziano V; Sierra S; Knops E; Schülter E; Jensen B; Oette M; Lengauer T; Kaiser R
    Intervirology; 2015; 58(3):184-9. PubMed ID: 26139571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues.
    Gallego O; de Mendoza C; Corral A; Soriano V
    AIDS; 2004 Mar; 18(4):689-90. PubMed ID: 15090775
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotype and antiretroviral drug resistance of human immunodeficiency virus-1 in Saudi Arabia.
    Jamjoom GA; Azhar EI; Madani TA; Hindawi SI; Bakhsh HA; Damanhouri GA
    Saudi Med J; 2010 Sep; 31(9):987-92. PubMed ID: 20844809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.
    Bon I; Alessandrini F; Borderi M; Gorini R; Re MC
    New Microbiol; 2007 Jul; 30(3):313-7. PubMed ID: 17802917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
    Anderson BD; Shirasaka T; Kojima E; Yarchoan R; Mitsuya H
    Antiviral Res; 1994 Dec; 25(3-4):245-58. PubMed ID: 7710271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new insertion in the HIV-1 reverse transcriptase gene inducing major resistance to non-nucleoside reverse transcriptase inhibitors.
    Amiel C; Desire N; Schneider V; Delphin N; Race E; Clavel F; Piolot T; Dam E; Rozenbaum W; Nicolas JC
    AIDS; 2005 Nov; 19(16):1922-4. PubMed ID: 16227805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.
    van der Hoek L; Back N; Jebbink MF; de Ronde A; Bakker M; Jurriaans S; Reiss P; Parkin N; Berkhout B
    J Virol; 2005 Mar; 79(6):3536-43. PubMed ID: 15731248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
    Brandin E; Lindborg L; Gyllensten K; Broström C; Hagberg L; Gisslen M; Tuvesson B; Blaxhult A; Albert J
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):543-50. PubMed ID: 12908931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colinearity of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing.
    Gonzales MJ; Johnson E; Dupnik KM; Imamichi T; Shafer RW
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):398-402. PubMed ID: 14615657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
    Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
    J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of antiretroviral drug resistance in therapy-naive HIV infected patients in Hungary.
    Juhász E; Ghidán A; Kemény B; Nagy K
    Acta Microbiol Immunol Hung; 2008 Dec; 55(4):383-94. PubMed ID: 19130746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
    Hecht FM; Grant RM; Petropoulos CJ; Dillon B; Chesney MA; Tian H; Hellmann NS; Bandrapalli NI; Digilio L; Branson B; Kahn JO
    N Engl J Med; 1998 Jul; 339(5):307-11. PubMed ID: 9682043
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequence analysis of proviral HIV RT amplified directly by a semi-quantitative technique from AZT treated patients.
    Stein CA; Levantis P; Oxford JS
    J Med Virol; 1994 Oct; 44(2):115-21. PubMed ID: 7531752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 proviral resistance mutations: usefulness in clinical practice.
    Kabamba-Mukadi B; Duquenne A; Henrivaux P; Musuamba F; Ruelle J; Yombi JC; Bodéus M; Vandercam B; Goubau P
    HIV Med; 2010 Sep; 11(8):483-92. PubMed ID: 20163482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of apparent resistance to all available antiretroviral drugs in a HIV-positive patient.
    Chibo D; Roth N; Birch C
    Sex Health; 2010 Mar; 7(1):82-4. PubMed ID: 20152102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral Resistance Mutations (revised April 2001).
    ;
    HIV Clin Trials; 2001; 2(4):346-55. PubMed ID: 11590539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.